Anne Wojcicki Reclaims 23andMe, $305M Deal
June 14, 2025
Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained ownership of the genetic-testing company through her nonprofit, TTAM Research Institute. Wojcicki’s group outbid Regeneron Pharmaceuticals on Friday, offering $305 million to acquire nearly all of 23andMe’s assets. These include its Personal Genome Service, research services, and its telehealth...
Read More